Details of the Drug

General Information of Drug (ID: DMQGI8R)

Drug Name
CD20 CAR T cells
Indication
Disease Entry ICD 11 Status REF
B-cell chronic lymphocytic leukaemia 2A82.00 Phase 2 [1]
Diffuse large B-cell lymphoma 2A81 Phase 2 [1]
Non-hodgkin lymphoma 2B33.5 Phase 2 [1]
Drug Type
CAR T Cell Therapy
Cross-matching ID
TTD ID
D0Y3HP
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Leukocyte surface antigen Leu-16 (CD20) TTUE541 CD20_HUMAN CAR-T-Cell-Therapy [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT02846584) a Clinical Research of Sequential CAR-T Bridging HSCT in the Treatment of Relapse/Refractory B-cell Malignancies